drugset

drugset / Trial / NCT00191867

Clinical Trial of Teriparatide in Japan

NCT00191867 ↗

Phase 2 Completed 160 enrolled Eli Lilly and Company

RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to assess the Efficacy and Safety of Teriparatide in Japanese Postmenopausal Women with Osteoporosis.

Timeline

Start: 2005-02
Primary completion: —
Completion: 2006-03

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Teriparatide	Protein / enzyme biologic	—	—

Indications